Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Open in API
Filings indexed 529 across all filing types
Latest filing 2023-02-04 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document contains an Independent Auditor's Review Report on Interim Standalone Financial Results for the quarter and nine months ended December 31, 2022, issued by Deloitte Haskins & Sells LLP. It references Regulation 33 of SEBI Listing Obligations and Disclosure Requirements, 2015, which pertains to interim financial reporting. The document includes detailed unaudited standalone financial results for the quarter and nine months ended December 31, 2022, with income, expenses, profit, tax, and earnings per share data. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year confirms this is an Interim / Quarterly Report. The document length (15,000 characters) and content confirm it is the report itself, not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2023-02-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an announcement for a Q3 FY23 earnings conference call scheduled for February 6, 2023. It includes dial-in details, a brief description of the company, and a disclaimer about forward-looking statements. There is no actual financial data or detailed financial analysis presented in the text. The document is clearly a notice about an upcoming earnings call rather than the transcript or the earnings release itself. Therefore, it fits best into the category of a Call Transcript (CT) if it were the transcript, but since this is only the announcement of the call, it is more appropriate to classify it as a Regulatory Filing (RNS) because it does not contain the transcript or the earnings release but only the call invitation and details. However, given the options and the nature of the document, the closest specific category is Call Transcript (CT) because it is related to the earnings call, but since it is only an announcement, the fallback Regulatory Filings (RNS) is more accurate. The document length is short (3261 characters), and it is an announcement rather than the transcript itself. Hence, the best classification is Regulatory Filings (RNS).
2023-02-01 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is extremely short (188 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of a report, announcement, or detailed information. It does not fit any specific report category and appears to be a minimal filing or certification. According to the rules, such minimal content defaults to Regulatory Filings (RNS).
2023-01-25 English
ESOP/ESOS/ESPS
Regulatory Filings Classification · 100% confidence The document is extremely short (268 characters) and contains only digital signature information without any substantive content or financial data. There is no indication of a report, announcement, or detailed filing. Given the lack of content and the presence of digital signatures only, this document does not fit into any specific report category and is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings.
2023-01-19 English
Updates
Regulatory Filings Classification · 100% confidence The document text is extremely short (134 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2023-01-10 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 90% confidence The document text is extremely short (246 characters) and contains no substantive content or financial data. It appears to be a signature block or a very brief note without any report or announcement details. There is no indication of a full report, announcement, or any specific filing type. Given the lack of content and the nature of the text, the best classification is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2023-01-06 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.